1. Home
  2. NOTV vs ZDGE Comparison

NOTV vs ZDGE Comparison

Compare NOTV & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • ZDGE
  • Stock Information
  • Founded
  • NOTV 1974
  • ZDGE 2008
  • Country
  • NOTV United States
  • ZDGE United States
  • Employees
  • NOTV N/A
  • ZDGE N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • ZDGE Computer Software: Prepackaged Software
  • Sector
  • NOTV Health Care
  • ZDGE Technology
  • Exchange
  • NOTV Nasdaq
  • ZDGE Nasdaq
  • Market Cap
  • NOTV 46.2M
  • ZDGE 51.8M
  • IPO Year
  • NOTV 1997
  • ZDGE N/A
  • Fundamental
  • Price
  • NOTV $1.34
  • ZDGE $3.14
  • Analyst Decision
  • NOTV Buy
  • ZDGE
  • Analyst Count
  • NOTV 3
  • ZDGE 0
  • Target Price
  • NOTV $5.25
  • ZDGE N/A
  • AVG Volume (30 Days)
  • NOTV 172.6K
  • ZDGE 79.3K
  • Earning Date
  • NOTV 08-08-2024
  • ZDGE 10-24-2024
  • Dividend Yield
  • NOTV N/A
  • ZDGE N/A
  • EPS Growth
  • NOTV N/A
  • ZDGE N/A
  • EPS
  • NOTV N/A
  • ZDGE N/A
  • Revenue
  • NOTV $501,062,000.00
  • ZDGE $29,142,000.00
  • Revenue This Year
  • NOTV N/A
  • ZDGE $13.67
  • Revenue Next Year
  • NOTV $8.69
  • ZDGE $13.41
  • P/E Ratio
  • NOTV N/A
  • ZDGE N/A
  • Revenue Growth
  • NOTV N/A
  • ZDGE 4.15
  • 52 Week Low
  • NOTV $1.29
  • ZDGE $1.70
  • 52 Week High
  • NOTV $11.42
  • ZDGE $5.18
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 33.17
  • ZDGE 42.90
  • Support Level
  • NOTV $1.37
  • ZDGE $3.05
  • Resistance Level
  • NOTV $1.63
  • ZDGE $3.88
  • Average True Range (ATR)
  • NOTV 0.12
  • ZDGE 0.27
  • MACD
  • NOTV -0.00
  • ZDGE -0.04
  • Stochastic Oscillator
  • NOTV 14.71
  • ZDGE 14.46

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

About ZDGE Zedge Inc. Class B

Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.

Share on Social Networks: